almagate has been researched along with Drug Hypersensitivity in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, SY; Coscas, G; Creuzot-Garcher, C; Devin, F; Gaudric, A; Korobelnik, JF; Mauget-Faysse, M; Sahel, JA; Soubrane, G; Souied, E; Tadayoni, R; Weber, M | 1 |
Azar, AE; Fuller, JJ; Muller, BA; Russell, SR; Steffensmeier, AC | 1 |
2 other study(ies) available for almagate and Drug Hypersensitivity
Article | Year |
---|---|
[Evolving intravitreous injection technique].
Topics: Adrenal Cortex Hormones; Antibiotic Prophylaxis; Aptamers, Nucleotide; Comorbidity; Contraindications; Drug Hypersensitivity; Eye Infections; Humans; Informed Consent; Injections; Macular Degeneration; Monitoring, Physiologic; Mydriatics; Practice Guidelines as Topic; Pupil; Retinal Artery Occlusion; Tonometry, Ocular; Unnecessary Procedures; Vitreous Body; Vitreous Hemorrhage | 2008 |
Vitreous injections of pegaptanib sodium triggering allergic reactions.
Topics: Aged, 80 and over; Anaphylaxis; Angiogenesis Inhibitors; Aptamers, Nucleotide; Choroidal Neovascularization; Diphenhydramine; Drug Hypersensitivity; Drug Therapy, Combination; Epinephrine; Humans; Injections; Male; Methylprednisolone; Urticaria; Vascular Endothelial Growth Factor A; Vitreous Body | 2007 |